Abbott Laboratories Gets Regulatory Authorization for Dual Glucose-Ketone Sensor

03:22 PM EDT, 08/25/2026 (MT Newswires) -- Abbott Laboratories (ABT) secured US Food and Drug Administration authorization for its dual glucose-ketone sensing wearable device. The Libre Duo 10 Day system can track glucose levels and alert people with diabetes of rising ketones that could lead to a diabetic ketoacidosis emergency, Abbott said Tuesday in a statement. The company plans to launch the device in the US later this year. Price: 116.24, Change: -0.43, Percent Change: -0.37